Bambalan, Gina Lee M.
HRN: 23-04-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2023
CEFUROXIME 500MG (TAB)
07/06/2023
07/12/2023
PO
500mg
BID
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes